Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer Stage IB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03907527
What this trial is testing

Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+31 more
Precigen, Inc 71
Early research (Phase 1)Study completedNCT03695380
What this trial is testing

A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer

Who this might be right for
OVARIAN CANCER
Hoffmann-La Roche 77
Early research (Phase 1)Active Not RecruitingNCT04092270
What this trial is testing

A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer

Who this might be right for
Endometrial High Grade Endometrioid AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+26 more
National Cancer Institute (NCI) 55
Early research (Phase 1)WithdrawnNCT00017537
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer

Who this might be right for
Breast CancerGastric CancerLung Cancer+2 more
University of Alabama at Birmingham
Early research (Phase 1)Ended earlyNCT01227941
What this trial is testing

MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011)

Who this might be right for
Ovarian Cancer
Tesaro, Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT03100006
What this trial is testing

Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin

Who this might be right for
Epithelial Ovarian Cancer
National Cancer Centre, Singapore 13
Testing effectiveness (Phase 2)Ended earlyNCT04826198
What this trial is testing

Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months

Who this might be right for
Ovarian Cancer
Gustave Roussy, Cancer Campus, Grand Paris 13
Testing effectiveness (Phase 2)WithdrawnNCT01982487
What this trial is testing

Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission

Who this might be right for
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer+30 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT06308406
What this trial is testing

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT01941316
What this trial is testing

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Who this might be right for
Small Cell Lung CarcinomaNon Small Cell Lung CarcinomaIrinotecan Sensitive Cancers
Cancer Research and Biostatistics Clinical Trials Consortium 78
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT01708161
What this trial is testing

A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors

Who this might be right for
PIK3CA Mutated Advanced Solid TumorsPIK3CA Amplified Advanced Solid Tumors
Novartis Pharmaceuticals 47
Early research (Phase 1)Study completedNCT01065662
What this trial is testing

AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

Who this might be right for
Endometrial CancerOvarian CancerCervical Cancer+2 more
Susana M. Campos, MD 11
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Large-scale testing (Phase 3)Active Not RecruitingNCT01081262
What this trial is testing

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

Who this might be right for
Borderline Ovarian Mucinous TumorOvarian Mucinous CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+21 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT01363232
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

Who this might be right for
Advanced Solid TumorsSelected Solid Tumors
Array Biopharma, now a wholly owned subsidiary of Pfizer 89
Large-scale testing (Phase 3)Study completedNCT00659373
What this trial is testing

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

Who this might be right for
Breast CancerFatigueSleep Disorders
ETOP IBCSG Partners Foundation 86
Testing effectiveness (Phase 2)Study completedNCT03318900
What this trial is testing

T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer

Who this might be right for
COL6A3 PositiveHLA-A*0201 Positive Cells PresentPRAME Positive+1 more
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07720180
What this trial is testing

Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab

Who this might be right for
Ovarian Cancer
Medical University of South Carolina 20
Next Page